| | Business Summary | | Texas
Biotechnology
Corporation
is
a
biopharmaceutical
company
focused
on
the
discovery,
development
and
commercialization
of
novel,
synthetic,
small-molecule
compounds
for
the
treatment
of
a
variety
of
cardiovascular,
vascular
and
related
inflammatory
diseases.
Its
research
and
development
programs
are
focused
on
inhibitors
(also
referred
to
as
antagonists
or
blockers)
that
can
interrupt
certain
disease
processes.
The
Company
programs
seek
to
address
unmet
medical
needs
in
cardiovascular
diseases,
thrombocytopenia,
pulmonary
hypertension,
heart
failure
and
inflammatory
diseases
such
as
asthma.
The
Company
has
five
major
product
development
programs.
These
include
The
Vasospasm/Hypertension
Program,
The
Vascular
Inflammation
Program,
Apoptosis
Program,
Angiogenesis
Program
and
Vascular
Proliferation
Disease
Program. | | More
from
Market Guide: Expanded
Business Description |
| | Financial Summary | | Texas
Biotechnology
Corp.
is
a
biopharmaceutical
company
focused
on
the
discovery,
development
and
commercialization
of
novel,
synthetic,
small
molecule
compounds
for
the
treatment
of
a
varierty
of
vascular
and
related
inflammatory
diseases.
For
the
six
months
ended
6/30/01,
revenues
fell
57%
to
$4.7
million.
Net
loss
before
acct.
change
totaled
$7
million
vs.
an
income
of
$1.3
million.
Results
reflect
the
absence
of
a
$7.5
million
milestone
payment
from
GSK. | | More
from
Market Guide: Significant
Developments |
| | Officers | | | FY2000
Compensation | | Pay | Exer | |
| John Pietruski, 68
Chairman,
Director | -- | -- | David McWilliams, 58
Pres,
CEO, Director | $564K | $524K | Richard Dixon, Ph.D., 47
Sr.
VP, Research, CSO | 402K | 516K | Pamela Murphy, 50
VP,
Corp. Communications | 227K | 65K | Joseph Welch, 60
VP
of Bus. Devel. | 277K | 129K | | Dollar
amounts are as of 31-Dec-2000 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.; "Exer" is the value of options excercised during the fiscal year. |
| More
from
Market Guide on Officers & Directors:
Expanded
List, Bios,
Compensation,
Options
|
|
![[one-year price graph]](http://chart.yahoo.com/c/0b/t/txbi.gif)